Efficacy and Safety of Paliperidone Extended Release 1.5 mg/day—A Double-blind, Placebo- and Active-Controlled, Study in the Treatment of Patients with Schizophrenia

BACKGROUND: Paliperidone extended-release (paliperidone ER) is an approved oral antipsychotic medication (dosing range 3–12 mg/day) for treatment of schizophrenia and schizoaffective disorder in adults. METHODS: In this 3-arm, double-blind, placebo- and active-controlled, parallel-group study, palip...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Psychopharmacol Bull
Main Authors: Coppola, Danielle, Melkote, Rama, Lannie, Caroline, Singh, Jaskaran, Nuamah, Isaac, Gopal, Srihari, Hough, David, Palumbo, Joseph
Formato: Artigo
Idioma:Inglês
Publicado em: MedWorks Media Global 2011
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5044480/
https://ncbi.nlm.nih.gov/pubmed/27738355
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados